Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-08-09 Sale |
2023-08-09 4:38 pm |
DICE Therapeutics Inc. | DICE | TETLOW SHARON Director |
49,841 | $0 | $0 | 0 (Direct) |
View |
| 2023-08-09 Sale |
2023-08-09 4:33 pm |
DICE Therapeutics Inc. | DICE | Scopa James Paul Director |
40,921 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2023-08-09 Sale |
2023-08-09 4:31 pm |
DICE Therapeutics Inc. | DICE | Robertson Scott M. CFO & CBO |
198,000 | $0 | $0 | 0 (Direct) |
View |
| 2023-08-09 Sale |
2023-08-09 4:29 pm |
DICE Therapeutics Inc. | DICE | SCHELLER RICHARD H Director |
8,427 | $0 | $0 | 0 (Direct) |
View |
| 2023-08-09 Sale |
2023-08-09 4:26 pm |
DICE Therapeutics Inc. | DICE | Timothy Lu CMO |
152,285 | $0 | $0 | 0 (Direct) |
View |
| 2023-08-09 Sale |
2023-08-09 4:25 pm |
DICE Therapeutics Inc. | DICE | Judice Kevin CEO |
799,685 | $0 | $0 | 0 (Direct) |
View |
| 2023-08-09 Sale |
2023-08-09 4:23 pm |
DICE Therapeutics Inc. | DICE | Jacobsen John R. CSO |
147,497 | $0 | $0 | 0 (Direct) |
View |
| 2023-06-22 Sale |
2023-06-23 5:36 pm |
DICE Therapeutics Inc. | DICE | Northpond Ventures GP LLC Northpond Ventures LP Northpond Ventures GP II LLC Northpond Ventures II LP Rubin Michael P. 10% Owner |
2,492,871 | $46.5 | $115,918,502 | 166,293 (Indirect) |
View |
| 2023-06-01 Sale |
2023-06-02 8:11 pm |
DICE Therapeutics Inc. | DICE | Jacobsen John R. CSO |
18,750 | $30.53 | $572,444 | 147,497 (Direct) |
View |
| 2023-05-05 Sale |
2023-05-09 6:02 pm |
DICE Therapeutics Inc. | DICE | SCHELLER RICHARD H Director |
84,097 | $38.51 | $3,238,205 | 8,427 (Direct) |
View |
| 2023-05-03 Sale |
2023-05-05 5:19 pm |
DICE Therapeutics Inc. | DICE | Robertson Scott M. CFO & CBO |
18,750 | $36.55 | $685,350 | 198,000 (Direct) |
View |
| 2023-05-03 Sale |
2023-05-05 5:10 pm |
DICE Therapeutics Inc. | DICE | Timothy Lu CMO |
10,000 | $36.54 | $365,398 | 152,285 (Direct) |
View |
| 2023-05-03 Sale |
2023-05-05 5:03 pm |
DICE Therapeutics Inc. | DICE | Judice Kevin CEO |
13,698 | $36.5 | $499,977 | 799,685 (Direct) |
View |
| 2023-04-18 Sale |
2023-04-19 7:28 pm |
DICE Therapeutics Inc. | DICE | Jacobsen John R. CSO |
16,392 | $30.08 | $493,127 | 166,247 (Direct) |
View |
| 2023-03-31 Sale |
2023-04-04 5:31 pm |
DICE Therapeutics Inc. | DICE | Jacobsen John R. CSO |
773 | $30 | $23,190 | 182,639 (Direct) |
View |
| 2023-03-28 Purchase |
2023-03-30 5:03 pm |
DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
509,145 | $29.07 | $14,798,693 | 7,856,612 (Indirect) |
View |
| 2023-03-28 Sale |
2023-03-30 4:35 pm |
DICE Therapeutics Inc. | DICE | Jacobsen John R. CSO |
1,594 | $30.03 | $47,867 | 183,412 (Direct) |
View |
| 2023-03-23 Purchase |
2023-03-27 5:01 pm |
DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
498,556 | $26.99 | $13,457,372 | 7,347,467 (Indirect) |
View |
| 2023-03-17 Sale |
2023-03-21 4:47 pm |
DICE Therapeutics Inc. | DICE | Scopa James Paul Director |
10,000 | $29.05 | $290,500 | 45,841 (Indirect Direct) |
View |
| 2022-10-17 Purchase |
2022-10-19 4:32 pm |
DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
1,640,000 | $36.5 | $59,860,000 | 6,848,911 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-08-09 Equity Swap |
2023-08-09 5:00 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Former 10% owners and Director Director |
7,856,612 | $0 | 0 (Indirect) |
View |
| 2023-08-02 Gift |
2023-08-03 7:37 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | Scopa James Paul Director |
2,420 | $0 | 40,921 (Indirect) |
View |
| 2023-07-18 Gift |
2023-07-19 4:53 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | Scopa James Paul Director |
2,200 | $0 | 43,341 (Indirect) |
View |
| 2023-07-11 Gift |
2023-07-13 5:12 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | Scopa James Paul Director |
300 | $0 | 45,541 (Indirect) |
View |
| 2023-05-01 Gift |
2023-05-02 5:49 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | Scopa James Paul Director |
6,923 | $0 | 45,841 (Direct) |
View |
| 2022-10-24 Gift |
2023-03-21 4:47 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | Scopa James Paul Director |
30,719 | $0 | 45,841 (Direct) |
View |
| 2023-01-27 Option Award |
2023-01-31 5:44 pm |
N/A 2033-01-26 |
DICE Therapeutics Inc. | DICE | Robertson Scott M. CFO & CBO |
131,250 | $0 | 131,250 (Direct) |
View |
| 2023-01-27 Option Award |
2023-01-31 5:37 pm |
N/A 2033-01-26 |
DICE Therapeutics Inc. | DICE | Timothy Lu CMO |
105,000 | $0 | 105,000 (Direct) |
View |
| 2023-01-27 Option Award |
2023-01-31 5:30 pm |
N/A 2033-01-26 |
DICE Therapeutics Inc. | DICE | Judice Kevin CEO |
350,000 | $0 | 350,000 (Direct) |
View |
| 2023-01-27 Option Award |
2023-01-31 5:25 pm |
N/A 2033-01-26 |
DICE Therapeutics Inc. | DICE | Jacobsen John R. CSO |
105,000 | $0 | 105,000 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-08 5:30 pm |
N/A 2032-06-06 |
DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
21,250 | $0 | 21,250 (Indirect) |
View |
| 2022-06-07 Option Award |
2022-06-08 5:06 pm |
N/A 2032-06-06 |
DICE Therapeutics Inc. | DICE | TETLOW SHARON Director |
21,250 | $0 | 21,250 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-08 5:01 pm |
N/A 2032-06-06 |
DICE Therapeutics Inc. | DICE | Simson Jake Director |
21,250 | $0 | 21,250 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-08 4:53 pm |
N/A 2032-06-06 |
DICE Therapeutics Inc. | DICE | Scopa James Paul Director |
21,250 | $0 | 21,250 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-08 4:48 pm |
N/A 2032-06-06 |
DICE Therapeutics Inc. | DICE | SCHELLER RICHARD H Director |
31,250 | $0 | 31,250 (Direct) |
View |
| 2022-04-14 Option Award |
2022-04-19 7:05 pm |
N/A 2032-04-14 |
DICE Therapeutics Inc. | DICE | Robertson Scott M. CFO & CBO |
154,250 | $0 | 154,250 (Direct) |
View |
| 2022-04-14 Option Award |
2022-04-19 7:00 pm |
N/A 2032-04-14 |
DICE Therapeutics Inc. | DICE | Timothy Lu CMO |
157,756 | $0 | 157,756 (Direct) |
View |
| 2022-04-14 Option Award |
2022-04-19 6:52 pm |
N/A 2032-04-14 |
DICE Therapeutics Inc. | DICE | Judice Kevin CEO |
384,900 | $0 | 384,900 (Direct) |
View |